Analysis of the priming activity of lipids generated during routine storage of platelet concentrates

Transfusion

Volumn 36, Issue 2, 1996, Pages 133-139

  Silliman, C C ^a   Dickey, W O ^b   Paterson, A J ^b   Thurman, G W ^b   Clay, K L ^c   Johnson, C A ^d   Ambruso, D R ^a,b  

^a Children's Hospital Colorado   (United States)

^b Bonfils Blood Center   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d Natl Jewish Ctr Immunol Resp M   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEPAFANT; LIPID; LYSOPHOSPHATIDYLCHOLINE; RECOMBINANT INTERLEUKIN 8; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NEUTROPHIL; THROMBOCYTE PRESERVATION;

EID: 0030068147     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36296181925.x     Document Type: Article

References (43)

1. Peterson VM, Ambruso DR Phagocyte production and function following burn injury. Austin, TX: R.G. Landes Company. 1994-60-82.
2. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 1973;52:741-4.
3. Lew PD. Receptors and intracellular signaling in human neutrophils. Am Rev Respir Dis 1990;141:S127-31.
4. Klebanoff SJ. Phagocytic cells: products of oxygen metabolism In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press. 1988:391-444.
5. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 1983;97:52-61.
6. Ohno Y, Seligmann BE, Gallin JI. Cytochrome b translocation to human neutrophil plasma membranes and superoxide release. J Biol Chem 1985;260:2409-14.
7. 2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J Biol Chem 1990;265:924-30.
8. Ingraham LM, Coates TD, Allen JM, et al. Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 1982;59:1259-66.
9. McPhail LC, Clayton CC, Snyderman R. The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem 1984;259:5768-75.
10. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984;160:1656-71.
11. Berton G, Zeni L, Cassatella MA, Rossi F. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 1986;138:1276-82.
12. Worthen GS, Seccombe JF, Clay K, et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced Superoxide secretion. J Immunol 1988;140:3553-9.
13. Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis J Pediatr 1990;116:960-4.
14. Sanchez Crespo M, Fernandez-Gallardo S. Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock. J Lipid Mediat 1991;4:127-43.
15. Heuer HO. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs. Lipids 1991;26:1374-80.
16. Vercellotti GM, Yin HQ, Gustafson KS, et al. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988;71:1100-7.
17. Rabinovici R, Esser KM, Lysko PG, et al. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res 1991;69:12-25.
18. Salzer WL, McCall CE. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 1990;85:1135-43.
19. Popovsky MA, Chaplin HC Jr, Moore SB. Transfusion-related acute lung injury. Transfusion 1993;33:444-5.
20. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-9.
21. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang 1992;63:133-6.
22. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994;124:684-94.
23. Walker RH, ed. Technical manual. 10th ed. Arlington: American Association of Blood Banks, 1990:19-58.
24. Ambruso DR, Bentwood B, Henson PM, Johnston RB Jr. Oxidative metabolism of cord blood neutrophils: relationship to content and degranulation of cytoplasmic granules. Pediatr Res 1984;18:1148-53.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
26. Rivnay B. Combined analysis of phospholipids by high-performance liquid chromatography and thin-layer chromatography: analysis of phospholipid classes in commercial soybean lecithin. J Chromatogr 1984;294:303-15.
27. Chilton FH, Murphy RC. Characterization of the arachidonate-containing molecular species of phosphoglycerides in the human neutrophil. Prostaglandins Leukot Med 1986;23:141-8.
28. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20-5.
29. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
30. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
31. Borish L, Rosenbaum R, Albury L, Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol 1989;121:280-9.
32. Tsujimoto M, Yokota S, Vilcek J, Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem Biophys Res Commun 1986;137:1094-100.
33. Le J, Vilcek I. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987;56:234-48.
34. Yuo A, Kitagawa S, Kasahara T, et al. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 1991;78:2708-14.
35. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
36. Wozniak A, Betts WH, Murphy GA, Rokicinski M. Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 1993;79:608-15.
37. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther 1990;255:962-8.
38. Seeds EA, Coyle AJ, Page CP. The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration. J Lipid Mediat 1991;4;111-21.
39. Lombardo JE, Cusack NA, Rajagopalan C, et al. Flow cytometric analysis of residual white blood cell concentration and platelet activation antigens in double filtered platelet concentrates. J Lab Clin Med 1993;122:557-66.
40. Muylle L, Wouters E, De Bock R, Peetermans ME. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Transfus Med 1992;2:289-93.
41. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7.
42. Clarke G, Podlosky L, Petrie L, Boshkov L. Severe respiratory reactions to random donor platelets: an incidence and nested case-control study (abstract). Blood 1994;84(Suppl 1):465a.
43. Silliman C, Pitman J, Thurman G, Ambruso D. Neutrophil (PMN) priming agents develop in patients with transfusion related acute lung injury (abstract). Blood 1992;80(Suppl 1):261a.